Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 39Carcinoma, Intraductal, Noninfiltrating 6Breast Carcinoma In Situ 5Inflammatory Breast Neoplasms 4Central Nervous System Neoplasms 3Liver Neoplasms 2Gliosarcoma 2Glioma 2Glioblastoma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Brain Neoplasms 2Astrocytoma 2Uveal Melanoma 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Sarcoma 1Recurrence 1Pheochromocytoma 1Ovarian Neoplasms 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1

Interventions

Magnetic Resonance Spectroscopy 2Tamoxifen 1Radiotherapy 1High-Energy Shock Waves 1Doxorubicin 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Carcinoma, Ductal, Breast × Tamoxifen × Clear all
NCT00002967 2013-06-21

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡